About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study of Galcanezumab in Healthy Participants

NCT02576951·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Eli Lilly and Company

Age

18–65

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Male and female healthy participants
Have a body mass index of 19.0 to 35.0 kilograms per meter square (kg/m²), inclusive

You may not be if

\- Currently smoke in excess of 5 cigarettes/day

The record

StatusCompleted

PhasePhase 1

Taking part178

StartedOct 2015

UpdatedFeb 26, 2019

Conditions

Where1

Covance
Dallas, Texas, United States

Clareo Health | A Study of Galcanezumab in Healthy Participants